Antithrombin Alfa Completed Phase 3 Trials for Disseminated Intravascular Coagulation (DIC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01384396A Clinical Study of KW-3357 in Patients With DIC
NCT01384903An Open-label Study of KW-3357